101 related articles for article (PubMed ID: 9480723)
1. Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.
Bachelez H; Flageul B; Dubertret L; Fraitag S; Grossman R; Brousse N; Poisson D; Knowles RW; Wacholtz MC; Haverty TP; Chatenoud L; Bach JF
J Autoimmun; 1998 Feb; 11(1):53-62. PubMed ID: 9480723
[TBL] [Abstract][Full Text] [Related]
2. HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris.
Skov L; Kragballe K; Zachariae C; Obitz ER; Holm EA; Jemec GB; Sølvsten H; Ibsen HH; Knudsen L; Jensen P; Petersen JH; Menné T; Baadsgaard O
Arch Dermatol; 2003 Nov; 139(11):1433-9. PubMed ID: 14623703
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept].
Mahiques L; Pitarch G; Sánchez-Carazo JL; Pérez-Ferriols A; Soriano CJ; Alegre V
Actas Dermosifiliogr; 2007 Oct; 98(8):539-44. PubMed ID: 17919428
[TBL] [Abstract][Full Text] [Related]
4. Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis.
Krueger JG; Walters IB; Miyazawa M; Gilleaudeau P; Hakimi J; Light S; Sherr A; Gottlieb AB
J Am Acad Dermatol; 2000 Sep; 43(3):448-58. PubMed ID: 10954656
[TBL] [Abstract][Full Text] [Related]
5. Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGF beta 1 transgenic mice.
Michaelis K; Wallbrecht K; Kerstan A; Beyersdorf N; Williams C; Kerkau T; Wang XJ; Hünig T; Schön MP
Exp Dermatol; 2010 May; 19(5):406-15. PubMed ID: 20100197
[TBL] [Abstract][Full Text] [Related]
6. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
7. The role of lesional T cells in recalcitrant psoriasis during infliximab therapy.
Bovenschen HJ; Van De Kerkhof PC; Gerritsen WJ; Seyger MM
Eur J Dermatol; 2005; 15(6):454-8. PubMed ID: 16280298
[TBL] [Abstract][Full Text] [Related]
8. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
9. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis.
Gottlieb AB; Kang S; Linden KG; Lebwohl M; Menter A; Abdulghani AA; Goldfarb M; Chieffo N; Totoritis MC
Clin Immunol; 2004 Apr; 111(1):28-37. PubMed ID: 15093549
[TBL] [Abstract][Full Text] [Related]
11. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
12. Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.
Bissonnette R; Langley RG; Papp K; Matheson R; Toth D; Hultquist M; Geba GP; White B
Arch Dermatol Res; 2009 Jul; 301(6):429-42. PubMed ID: 19471949
[TBL] [Abstract][Full Text] [Related]
13. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
Rep MH; van Oosten BW; Roos MT; Adèr HJ; Polman CH; van Lier RA
J Clin Invest; 1997 May; 99(9):2225-31. PubMed ID: 9151795
[TBL] [Abstract][Full Text] [Related]
14. The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.
Papp K; Bissonnette R; Krueger JG; Carey W; Gratton D; Gulliver WP; Lui H; Lynde CW; Magee A; Minier D; Ouellet JP; Patel P; Shapiro J; Shear NH; Kramer S; Walicke P; Bauer R; Dedrick RL; Kim SS; White M; Garovoy MR
J Am Acad Dermatol; 2001 Nov; 45(5):665-74. PubMed ID: 11606914
[TBL] [Abstract][Full Text] [Related]
15. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
16. Circulating CLA+ T cell subsets inversely correlate with disease severity and extension in acute psoriasis but not in chronic plaque psoriasis.
Ferran M; Giménez-Arnau AM; Bellosillo B; Pujol RM; Santamaria-Babi LF
Eur J Dermatol; 2008; 18(6):647-50. PubMed ID: 18955198
[TBL] [Abstract][Full Text] [Related]
17. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
[TBL] [Abstract][Full Text] [Related]
18. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
19. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
[TBL] [Abstract][Full Text] [Related]
20. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
